For Fundracer Partner René Wiertz, the next decade will not simply be about selling more bicycles; it will be about making two-wheel mobility dramatically safer, smarter and more connected. "Those companies enabling that transformation are likely to create the greatest long-term value," says Wiertz. Bike Europe asked him about the market outlook from the perspective of an investment fund manager.
Following Accell Group's Dutch suspension of payments, international subsidiaries are taking control of their own fate. Cycles Lapierre has filed for judicial reorganisation in France, while Accell UK & Ireland (Raleigh) has lodged a notice to appoint administrators.
Contactless torque sensor manufacturer NCTE reports a year-on-year sales increase of 53% in the first half of 2026. One of the biggest drivers of NCTE's expansion has been the e-bike category, while the automotive category performed weakly. Remarkably, the company's stock market performance was much less positive; it suffered a 66.6% decline in the first half of 2026.
Despite a continuing challenging market environment, kids and youth bicycle brand woom posted a significantly positive result and thus returned to profitability. In the first half of 2026, the Austrian company continued to build on the revenue growth achieved in the previous year. Woom reports a 19% revenue increase from January to June 2026, to €107 million.
Chinese investors were less active in the bicycle industry in the past than it appeared from the outside. To date, there have been very few known investments by the Chinese in Western companies. Since 2015, corporate acquisitions by Chinese investors have mainly involved Asian companies, with the target firms mostly being bicycle component manufacturers. Why are there relatively few takeovers by Chinese investors in our sector?
The transfer of Accell Group to the new owner, the Singapore-based investment firm DuTech Group, passed another regulatory milestone. The Polish anti-competition authorities, UOKiK, identified no concerns significant enough to justify remedies or prohibit the transaction, and therefore approved the acquisition.
